Exact Mass: 578.3302
Exact Mass Matches: 578.3302
Found 500 metabolites which its exact mass value is equals to given mass value 578.3302
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Oscillatoxin A
Chenodeoxycholyltryptophan
Chenodeoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyltryptophan consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Deoxycholyltryptophan
Deoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyltryptophan consists of the bile acid deoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
3alpha-Angeloyloxy-18beta-glucopyranosyloxy-ent-labd-8(17),13-dien-15,16-olide
Macrolactin P
7-hydroxy-23,24-dihydrocucurbitacin F 25-O-acetate|Hemslecin G
16beta-Acetoxy-14-hydroxy-3beta-alpha-L-rhamnopyranosyloxy-5beta,14beta-card-20(22)-enolid|16beta-acetoxy-14-hydroxy-3beta-alpha-L-rhamnopyranosyloxy-5beta,14beta-card-20(22)-enolide
(7S,8R,8R,4S,5S,7S,10S)-9-O-(11-hydroxyeudesman-4-yl)-dihydrosesamin
16-O-acetyl-hydroxyperiplogenin 3-O-beta-D-digitoxopyranoside
10beta,12,14-trihydroxyalloaromadendrane 12,14-di-O-beta-D-glucopyranoside|dendroside B
Tyr Gln Ile Arg
C32H50O9_beta-D-Xylopyranoside, 3,17-dihydroxyspirost-5-en-1-yl
Difebarbamate
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
putative tryptophane conjugated chenodeoxycholic acid
putative tryptophane conjugated chenodeoxycholic acid (clustered spectrum)
Ala Phe Arg Trp
Ala Phe Trp Arg
Ala Arg Phe Trp
Ala Arg Trp Phe
Ala Trp Phe Arg
Ala Trp Arg Phe
Glu Phe Lys Arg
Glu Phe Arg Lys
Glu Lys Phe Arg
Glu Lys Arg Phe
Glu Arg Phe Lys
Glu Arg Lys Phe
Phe Ala Arg Trp
Phe Ala Trp Arg
Phe Glu Lys Arg
Phe Glu Arg Lys
Phe His Ile Tyr
Phe His Leu Tyr
Phe His Tyr Ile
Phe His Tyr Leu
Phe Ile His Tyr
Phe Ile Asn Trp
Phe Ile Trp Asn
Phe Ile Tyr His
Phe Lys Glu Arg
Phe Lys Arg Glu
Phe Lys Val Trp
Phe Lys Trp Val
Phe Leu His Tyr
Phe Leu Asn Trp
Phe Leu Trp Asn
Phe Leu Tyr His
Phe Asn Ile Trp
Phe Asn Leu Trp
Phe Asn Trp Ile
Phe Asn Trp Leu
Phe Gln Val Trp
Phe Gln Trp Val
Phe Arg Ala Trp
Phe Arg Glu Lys
Phe Arg Lys Glu
Phe Arg Arg Thr
Phe Arg Thr Arg
Phe Arg Trp Ala
Phe Thr Arg Arg
Phe Val Lys Trp
Phe Val Gln Trp
Phe Val Trp Lys
Phe Val Trp Gln
Phe Trp Ala Arg
Phe Trp Ile Asn
Phe Trp Lys Val
Phe Trp Leu Asn
Phe Trp Asn Ile
Phe Trp Asn Leu
Phe Trp Gln Val
Phe Trp Arg Ala
Phe Trp Val Lys
Phe Trp Val Gln
Phe Tyr His Ile
Phe Tyr His Leu
Phe Tyr Ile His
Phe Tyr Leu His
His Phe Ile Tyr
His Phe Leu Tyr
His Phe Tyr Ile
His Phe Tyr Leu
His Ile Phe Tyr
His Ile Tyr Phe
His Leu Phe Tyr
His Leu Tyr Phe
His Tyr Phe Ile
His Tyr Phe Leu
His Tyr Ile Phe
His Tyr Leu Phe
Ile Phe His Tyr
Ile Phe Asn Trp
Ile Phe Trp Asn
Ile Phe Tyr His
Ile His Phe Tyr
Ile His Tyr Phe
Ile Lys Arg Tyr
Ile Lys Tyr Arg
Ile Asn Phe Trp
Ile Asn Trp Phe
Ile Gln Arg Tyr
Ile Gln Tyr Arg
Ile Arg Lys Tyr
Ile Arg Gln Tyr
Ile Arg Tyr Lys
Ile Arg Tyr Gln
Ile Trp Phe Asn
Ile Trp Asn Phe
Ile Tyr Phe His
Ile Tyr His Phe
Ile Tyr Lys Arg
Ile Tyr Gln Arg
Ile Tyr Arg Lys
Ile Tyr Arg Gln
Lys Glu Phe Arg
Lys Glu Arg Phe
Lys Phe Glu Arg
Lys Phe Arg Glu
Lys Phe Val Trp
Lys Phe Trp Val
Lys Ile Arg Tyr
Lys Ile Tyr Arg
Lys Leu Arg Tyr
Lys Leu Tyr Arg
Lys Arg Glu Phe
Lys Arg Phe Glu
Lys Arg Ile Tyr
Lys Arg Leu Tyr
Lys Arg Tyr Ile
Lys Arg Tyr Leu
Lys Val Phe Trp
Lys Val Trp Phe
Lys Trp Phe Val
Lys Trp Val Phe
Lys Tyr Ile Arg
Lys Tyr Leu Arg
Lys Tyr Arg Ile
Lys Tyr Arg Leu
Leu Phe His Tyr
Leu Phe Asn Trp
Leu Phe Trp Asn
Leu Phe Tyr His
Leu His Phe Tyr
Leu His Tyr Phe
Leu Lys Arg Tyr
Leu Lys Tyr Arg
Leu Asn Phe Trp
Leu Asn Trp Phe
Leu Gln Arg Tyr
Leu Gln Tyr Arg
Leu Arg Lys Tyr
Leu Arg Gln Tyr
Leu Arg Tyr Lys
Leu Arg Tyr Gln
Leu Trp Phe Asn
Leu Trp Asn Phe
Leu Tyr Phe His
Leu Tyr His Phe
Leu Tyr Lys Arg
Leu Tyr Gln Arg
Leu Tyr Arg Lys
Leu Tyr Arg Gln
Asn Phe Ile Trp
Asn Phe Leu Trp
Asn Phe Trp Ile
Asn Phe Trp Leu
Asn Ile Phe Trp
Asn Ile Trp Phe
Asn Leu Phe Trp
Asn Leu Trp Phe
Asn Trp Phe Ile
Asn Trp Phe Leu
Asn Trp Ile Phe
Asn Trp Leu Phe
Gln Phe Val Trp
Gln Phe Trp Val
Gln Ile Arg Tyr
Gln Ile Tyr Arg
Gln Leu Arg Tyr
Gln Leu Tyr Arg
Gln Arg Ile Tyr
Gln Arg Leu Tyr
Gln Arg Tyr Ile
Gln Arg Tyr Leu
Gln Val Phe Trp
Gln Val Trp Phe
Gln Trp Phe Val
Gln Trp Val Phe
Gln Tyr Ile Arg
Gln Tyr Leu Arg
Gln Tyr Arg Ile
Gln Tyr Arg Leu
Arg Ala Phe Trp
Arg Ala Trp Phe
Arg Glu Phe Lys
Arg Glu Lys Phe
Arg Phe Ala Trp
Arg Phe Glu Lys
Arg Phe Lys Glu
Arg Phe Arg Thr
Arg Phe Thr Arg
Arg Phe Trp Ala
Arg Ile Lys Tyr
Arg Ile Gln Tyr
Arg Ile Tyr Lys
Arg Ile Tyr Gln
Arg Lys Glu Phe
Arg Lys Phe Glu
Arg Lys Ile Tyr
Arg Lys Leu Tyr
Arg Lys Tyr Ile
Arg Lys Tyr Leu
Arg Leu Lys Tyr
Arg Leu Gln Tyr
Arg Leu Tyr Lys
Arg Leu Tyr Gln
Arg Gln Ile Tyr
Arg Gln Leu Tyr
Arg Gln Tyr Ile
Arg Gln Tyr Leu
Arg Arg Phe Thr
Arg Arg Thr Phe
Arg Thr Phe Arg
Arg Thr Arg Phe
Arg Trp Ala Phe
Arg Trp Phe Ala
Arg Tyr Ile Lys
Arg Tyr Ile Gln
Arg Tyr Lys Ile
Arg Tyr Lys Leu
Arg Tyr Leu Lys
Arg Tyr Leu Gln
Arg Tyr Gln Ile
Arg Tyr Gln Leu
Thr Phe Arg Arg
Thr Arg Phe Arg
Thr Arg Arg Phe
Val Phe Lys Trp
Val Phe Gln Trp
Val Phe Trp Lys
Val Lys Phe Trp
Val Lys Trp Phe
Val Trp Phe Lys
Val Trp Lys Phe
Trp Ala Phe Arg
Trp Ala Arg Phe
Trp Phe Ala Arg
Trp Phe Lys Val
Trp Phe Arg Ala
Trp Phe Val Lys
Trp Lys Phe Val
Trp Lys Val Phe
Trp Arg Ala Phe
Trp Arg Phe Ala
Trp Val Phe Lys
Trp Val Lys Phe
Tyr Ile Lys Arg
Tyr Ile Gln Arg
Tyr Ile Arg Lys
Tyr Ile Arg Gln
Tyr Lys Ile Arg
Tyr Lys Leu Arg
Tyr Lys Arg Ile
Tyr Lys Arg Leu
Tyr Leu Lys Arg
Tyr Leu Gln Arg
Tyr Leu Arg Lys
Tyr Leu Arg Gln
Tyr Gln Leu Arg
Tyr Gln Arg Ile
Tyr Gln Arg Leu
Tyr Arg Ile Lys
Tyr Arg Ile Gln
Tyr Arg Lys Ile
Tyr Arg Lys Leu
Tyr Arg Leu Lys
Tyr Arg Leu Gln
Tyr Arg Gln Ile
Tyr Arg Gln Leu
3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloartane-23-one-3-O-beta-D-xylopyranoside
3-[(2E,5E)-5-[[3,5-bis(ethenyl)-4-methyl-1H-pyrrol-2-yl]methylidene]-2-[[3-(2-carboxyethyl)-5-[(E)-(4-ethenyl-3-methylpyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-4-methylpyrrol-3-yl]propanoic acid
2-[[(2R)-3-acetyloxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
sodium globostellatate B
An organic sodium salt that is the monosodium salt of globostellatic acid B. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.
sodium globostellatate C
An organic sodium salt that is the monosodium salt of globostellatic acid C. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.
buxalongifolamidine
A natural product found in Buxus natalensis and Buxus longifolia.
(1S,3R,4S,9R,13S,14R)-13-hydroxy-9-(hydroxymethyl)-3-[(2S,5S)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione
3-[(2Z,5Z)-5-[[2,4-bis(ethenyl)-3-methyl-2H-pyrrol-1-ium-5-yl]methylidene]-2-[[3-(2-carboxylatoethyl)-5-[(Z)-(4-ethenyl-3-methylpyrrol-1-ium-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-4-methylpyrrol-3-yl]propanoate
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
4-(dimethylamino)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
4-(dimethylamino)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
4-(dimethylamino)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
4-(dimethylamino)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
4-(dimethylamino)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
[(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
3-[(2Z,5Z)-5-[[2,4-bis(ethenyl)-3-methyl-2H-pyrrol-5-yl]methylidene]-2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methylpyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-4-methylpyrrol-3-yl]propanoic acid
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-phosphonooxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
Spacer phosphoramidite C3
Spacer phosphoramidite C3 is a phosphorite monomer that can be used in the synthesis of oligonucleotides.
2-[(2s,4as,8s,8as)-8-{[(2s,3r,4r)-2-(2h-1,3-benzodioxol-5-yl)-4-(2h-1,3-benzodioxol-5-ylmethyl)oxolan-3-yl]methoxy}-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-ol
3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(4ar,5s,6r,8ar)-5-{2-[1-(4-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-5-oxo-2h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
2-{[3-hydroxy-8a-methyl-4-methylidene-6-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-octahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2s,3s,4r,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl (9s)-9-methylheptadecanoate
11-hydroxy-20-(hydroxymethyl)-16-methoxy-6,6,7,20-tetramethyl-10,18-bis(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraene-13,17-dione
(17e,19e)-21-ethyl-9,11,16-trihydroxy-13-methoxy-10,12,16,18,24-pentamethyl-2,22,26-trioxatricyclo[19.3.1.1⁵,⁸]hexacosa-5,17,19-triene-3,7,23-trione
(1r,2r,7r,16s,18s,20r)-11-hydroxy-20-(hydroxymethyl)-16-methoxy-6,6,7,20-tetramethyl-10,18-bis(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraene-13,17-dione
(1s,3r,4s,5s,9r,13s,14r)-13-hydroxy-9-(hydroxymethyl)-3-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecane-7,11-dione
3-(2,4-dihydroxy-6-pentylbenzoyloxy)-5-pentylphenyl 2-hydroxy-4-methoxy-6-propylbenzoate
(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-3-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate
(2r,3r,5r,7r,10s)-atractyloside g 2-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN006446","Ingredient_name": "(2r,3r,5r,7r,10s)-atractyloside g 2-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H46O13","Ingredient_Smile": "CC12CCC(CC1C(=C)C(C(C2)OC3C(C(C(C(O3)CO)O)O)O)O)C(C)(C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14424","TCMID_id": "1980","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}